CytoSorbents to Present at the Oppenheimer 31st Annual Healthcare Conference
- Friday, March 12, 2021, 7:15
- PR Newswire
- Add a comment
MONMOUTH JUNCTION, N.J., March 12, 2021 /PRNewswire/ — CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world,…
About the Author
admin has written 21793 stories on this site.